Navigation Links
How Long Will the Economic Downturn Affect the Dental Biomaterials Market?
Date:3/24/2009

Despite minimal growth in 2009, the US dental biomaterials market will rebound to reach upwards of $230 million by 2013, according to Millennium Research Group

WALTHAM, Mass., March 24 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Dental Biomaterials 2009 report, although dental biomaterials are being used in a growing proportion of dental implant procedures, the market for these products will be dampened by the global financial crisis in the coming years as many patients postpone dental implant procedures or choose less expensive alternatives such as crowns.

Nonetheless, the US market for dental biomaterials continued to grow in 2008 due to several significant market events: BIOMET 3i's Endobon and NovaBone's NovaBone were launched in the US in the second quarter of 2008; the US import ban on Straumann's Emdogain and BoneCeramic we lifted in August, making these products available toward the end of the year; Curasan's dental business was purchased by RIEMSER Arzneimittel, a German pharmaceutical company; Regeneration Technologies and Tutogen Medical merged and now operate under the new name RTI Biologics; and Lifecore Biomedical's dental division merged with Keystone Dental following Lifecore Biomedical's acquisition by Warburg Pincus.

"These events supported market expansion in 2008 and highlight the revenue potential in the dental biomaterial space," says Kevin Flewwelling, Manager of the Orthopedics division at MRG. "Although 2009 will be a challenging year for dental biomaterial sales, market growth will continue through 2013."

MRG's US Markets for Dental Biomaterials 2009 report provides coverage of key industry competitors, including ACE Surgical Supply, BioHorizons, BIOMET 3i, DENTSPLY Friadent, Geistlich, GORE Medical Products, Keystone Dental, LifeNet Health, NovaBone Products, Osteogenics Biomedical, Osteohealth, RIEMSER Arzneimittel (incl. Curasan), RTI Biologics, Straumann, and many more.

About Millennium Research GroupMillennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry
2. Healthcare Executives Will Discuss How Best to Spend Economic Stimulus Money at June Conference
3. Life Science Labs Reacting to the Economic Crisis
4. Despite Economic Woes, Physician Compensation Increases
5. Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22
6. Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)
7. Histogen Featured on Economic Report Television Series
8. NSD Bio Group, LLC chosen by U.S.-China Economic & Security Review Commission for Report on Chinas High Tech Sectors
9. North Carolinas Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs
10. In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance
11. OncoGenex increases economic interest in lead cancer drug OGX-011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing and ... results for the third quarter and first nine months ... Third Quarter of Fiscal 2017 Highlights ... increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... -- VWR Corporation (NASDAQ: VWR), the leading global independent provider of ... reported its financial results for the fourth quarter and full ... 4Q16 record quarterly net sales of $1.13 billion, ... 4Q16 EMEA-APAC segment net sales ... Americas net sales increased 2.5%, or down 0.9% on an ...
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... , its innovative, highly flexible and award winning ... customers. iMedNet is a proven Software-as-a-Service ... Electronic Data Capture (EDC), but also delivers an entire ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
Breaking Biology News(10 mins):